U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07532330) titled 'Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo' on April 08.
Brief Summary: The goal of this clinical trial is to learn if adding topical tacrolimus or topical tyrosine to narrowband UVB phototherapy works to treat vitiligo in adults. It will also learn about the safety of both combinations.
The main questions it aims to answer are:
Which combination (UVB + tacrolimus or UVB + tyrosine) leads to greater skin repigmentation (color return) after 3 months of treatment? What side effects do participants experience with each combination? Researchers will compare three groups: UVB + tacrolimus, UVB + tyrosine, and UVB only to see which...